Part, Chapter, Paragraph
1 II, 5. 1. 1| countries, cardiovascular complications and neoplasia represent
2 II, 5. 1. 3| condition and prevent avoidable complications, while maintaining or improving
3 II, 5. 2. 3| which represent common complications of AMI and require frequent
4 II, 5. 4. 1| and heart. Microvascular complications (diabetic retinopathy, nephropathy
5 II, 5. 4. 1| the occurrence of major complications is more difficult to avoid.
6 II, 5. 4. 1| a rise with the onset of complications. Indirect costs by diabetes
7 II, 5. 4. 1| representation.~Severe long term complications are observed in both forms
8 II, 5. 4. 1| in the increased risk of complications, affecting both small blood
9 II, 5. 4. 1| vessels (macro-vascular complications including vision loss, nerve
10 II, 5. 4. 1| vessels (macro-vascular complications such as myocardial infarction
11 II, 5. 4. 1| prevent and/or reduce such complications.~Main complications of diabetes
12 II, 5. 4. 1| such complications.~Main complications of diabetes are as follows:~
13 II, 5. 4. 1| stillbirth.~Cardiovascular complications: Long lasting hyperglycaemia
14 II, 5. 4. 2| targets for the reduction of complications and the development of an
15 II, 5. 4. 2| paramount to prevent diabetes complications, but it is not an easy matter
16 II, 5. 4. 2| diabetes and particularly its complications - blindness, renal failure,
17 II, 5. 4. 2| linked to the occurrence of complications, is increasingly considered
18 II, 5. 4. 2| define estimates of rates of complications that are frequently recorded
19 II, 5. 4. 2| system on diabetes and its complications of this nature across Europe.
20 II, 5. 4. 2| Registries~IV Epidemiology of complications~ ~ ~Annual incidence of
21 II, 5. 4. 2| patients die from macrovascular complications, which lead to record diabetes
22 II, 5. 4. 2| only~2~III Risk factors for complications~ ~Percent of diabetic subjects
23 II, 5. 4. 2| bands~2~IV Epidemiology of complications~ ~Percent of diabetic subjects
24 II, 5. 4. 2| that can lead to severe complications. It is defined as the percentage
25 II, 5. 4. 2| existence of ophthalmologic complications. The process indicator is
26 II, 5. 4. 3| burden of diabetes and its complications, remain scarce both in the
27 II, 5. 4. 6| tools and policies~Long term complications, observed in both forms
28 II, 5. 4. 6| considerably to the reduction of complications, something even more important
29 II, 5. 4. 6| non-diagnosed patients (prior to complications), which translates into
30 II, 5. 4. 6| diagnosis made when the first complications are already present.~According
31 II, 5. 4. 6| of this disease and its complications, as well as the possible
32 II, 5. 4. 6| diabetes mellitus and its complications in the EU requires carefully
33 II, 5. 4. 6| the reduction of diabetes complications. A fundamental guideline
34 II, 5. 4. 6| development of diabetes complications;~· Adoption of a holistic,
35 II, 5. 4. 7| clinical measurements, diabetes complications);~· health system (structures,
36 II, 5. 5. 3| sexual dysfunction, obstetric complications, cardiovascular diseases,
37 II, 5. 5. 3| types, circumstances and complications: a European cohort study.
38 II, 5. 7. 1| risk for cardiovascular complications. Independent from other
39 II, 5. 7. 1| risk for cardiovascular complications which is 2-4 times higher
40 II, 5. 7. 1| resulting cardiovascular complications (Chobanian et al, 2003;
41 II, 5. 7. 1| death and other clinical complications in other chronic diseases
42 II, 5. 7. 3| showing a higher risk for CV complications and for evolution to ESRD (
43 II, 5. 7. 5| for CKD. When the risk of complications due to modifiable factors
44 II, 5. 8. 1| co-morbidities and severe systemic complications.~ ~Major efforts in the
45 II, 5. 8. 3| COPD follow-up, 25% to COPD complications and exacerbations, and 34%
46 II, 5. 12. 5| it is possible to reduce complications and related mortality through
47 II, 6. 3. 3| lead to severe long-term complications such as ectopic (outside
48 II, 6. 3. 5| may suffer from serious complications, including deafness, neurological
49 II, 9 | intrapartum and neonatal complications including pregnancy induced
50 II, 9. 1 | status are associated with complications of the perinatal period,
51 II, 9. 1. 1| Elevated risks of pregnancy complications and adverse outcomes with
52 II, 9. 1. 2| intrapartum and neonatal complications including pregnancy induced
53 II, 9. 3. 2| more frequent obstetric complications and diseases. Maternal morbidity
54 II, 9. 3. 2| infections/sepsis, obstetrical complications, and ‘indirect’ causes,
55 II, 9. 3. 2| Elevated risks of pregnancy complications and adverse outcomes with
56 II, 9. 4. 3| Federation, 2003). Long-term complications affect older people making
57 III, 10. 2. 1| in pregnancy~- Pregnancy complications~- Preterm delivery~- Foetal
58 III, 10. 2. 1| pregnancy and early childhood complications. The association with the
59 III, 10. 2. 1| and can lead to surgical complications and a greater likelihood
60 III, 10. 2. 1| consumption patterns and the complications caused by the combined use
61 III, 10. 4. 2| included with associated complications regarding the tasks EFSA
62 IV, 11. 1. 5| delivery, miscommunication, complications in payment systems, etc. (
63 IV, 11. 1. 5| lead to greater medical complications or even deaths. In addition,
64 IV, 12. 2 | Diabetes~ ~Long term complications, observed in both forms
65 IV, 12. 2 | non-diagnosed patients (prior to complications) with the diagnosis made
66 IV, 12. 2 | diagnosis made when the first complications are already present.~ ~The
